Access cutting-edge breast cancer treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Tucson at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this breast cancer clinical trial in Tucson, AZ
If you're searching for breast cancer treatment options in Tucson, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.